Mayne Pharma Group (MAYNF) News Today $3.33 0.00 (0.00%) As of 06/27/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock MAYNF Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Mayne Pharma Group Limited (MAYNF) - Yahoo FinanceJune 29 at 9:04 AM | sg.finance.yahoo.comVanguard Group Ceases to be Substantial Holder in Mayne PharmaJune 24, 2025 | tipranks.comHealth Check: Mayne Pharma shareholders back $600m ‘phantom’ takeover offerJune 17, 2025 | msn.comMayne Pharma Shareholders Approve Acquisition by Cosette PharmaceuticalsJune 17, 2025 | tipranks.comMayne Pharma to be Acquired by Cosette PharmaceuticalsJune 17, 2025 | tipranks.comMayne Pharma Engages in Legal Battle with Cosette Over Scheme TerminationJune 15, 2025 | tipranks.comProxy advisers support Mayne Pharma deal as suitor tries to exitJune 8, 2025 | afr.comMayne Pharma’s Scheme Meeting to Proceed Amidst Cosette’s Termination NoticeJune 4, 2025 | tipranks.comMayne Pharma Updates on Cosette Scheme and FDA ClearanceJune 3, 2025 | tipranks.comMayne Pharma shares keep sliding amid ASX questioningMay 23, 2025 | msn.comCosette confirms review of $672m Mayne Pharma acquisitionMay 22, 2025 | msn.comMayne Pharma nosedive deepens as Cosette mulls scrapping $672M buy-upMay 22, 2025 | msn.comWhy a private equity group is rethinking its bid for Mayne PharmaMay 21, 2025 | afr.comMayne Pharma slumps 30% as Cosette threatens to scrap $432 million dealMay 20, 2025 | reuters.comMayne Pharma shares crash after suitor Cosette raises concernsMay 20, 2025 | afr.comMayne Pharma Disputes Cosette’s Material Adverse Change Claim Amid Acquisition DealMay 20, 2025 | tipranks.comMayne Pharma Initiates Trading Halt Amid Acquisition TalksMay 18, 2025 | tipranks.comMayne Pharma Addresses Market Speculation Following FDA LetterMay 14, 2025 | tipranks.comMayne Pharma Addresses Compliance Oversight in Director’s Interest DisclosureMay 11, 2025 | tipranks.comMAYNF Mayne Pharma Group LimitedApril 25, 2025 | seekingalpha.comMayne Pharma Reports Revenue Growth and New Licensing AgreementApril 21, 2025 | tipranks.comMayne Pharma Faces Legal Challenge from TherapeuticsMDApril 10, 2025 | tipranks.comState Street Corporation Becomes Substantial Holder in Mayne PharmaApril 2, 2025 | msn.comAnalysts Offer Insights on Healthcare Companies: OrthoPediatrics (KIDS) and Mayne Pharma Group (OtherMAYNF)March 4, 2025 | markets.businessinsider.comMayne Pharma expects earnings to triple, shares jump 25pcFebruary 10, 2025 | afr.comDiscover ASX Penny Stocks Featuring Mayne Pharma Group And Two OthersJanuary 30, 2025 | uk.finance.yahoo.comMayne Pharma Group Reports Cessation of SecuritiesDecember 6, 2024 | tipranks.comMayne Pharma Issues New Employee Incentive SecuritiesDecember 6, 2024 | tipranks.comWilsons Keeps Their Buy Rating on Mayne Pharma Group (MAYNF)December 3, 2024 | markets.businessinsider.comMayne Pharma Sees Strong Support at Annual MeetingNovember 21, 2024 | markets.businessinsider.comFEDERAL CONTRACEPTION PROPOSAL TO EXPAND ACCESS AND AFFORDABLE COVERAGE PAVES A STRONGER PATH FOR MAYNE PHARMA'S GROWTH IN WOMEN'S HEALTHNovember 4, 2024 | prnewswire.comMayne Pharma Hosts Investor Webinar on US Business SegmentsOctober 30, 2024 | markets.businessinsider.comMayne Pharma to Highlight Growth in US Health SectorsOctober 23, 2024 | markets.businessinsider.comMayne Pharma Group (MAYNF) Receives a Buy from Canaccord GenuitySeptember 22, 2024 | markets.businessinsider.comAustralia's Mayne Pharma sues Sun Pharma over patent infringementJuly 25, 2024 | msn.comMayne Pharma Group LtdJuly 25, 2024 | reuters.comSun Pharma share price hits 52-week high, despite getting sued by Australia's Mayne Pharma, over patent infringementJuly 25, 2024 | msn.comMayne Pharma Group Limited's (ASX:MYX) largest shareholders are individual investors with 38% ownership, institutions own 33%May 12, 2024 | finance.yahoo.comMayne Pharma Group LimitedApril 23, 2024 | afr.comMayne Pharma Group Limited (MAYNF) Q2 2024 Earnings Call TranscriptFebruary 28, 2024 | seekingalpha.comMayne Pharma Group Limited (MAYNF)February 28, 2024 | finance.yahoo.comMayne Pharma Group reports 1H resultsFebruary 27, 2024 | msn.comMayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceDecember 29, 2023 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Replimune Group (REPL), Mayne Pharma Group (OtherMAYNF) and Biogen (BIIB)December 6, 2023 | markets.businessinsider.comWhile institutions invested in Mayne Pharma Group Limited (ASX:MYX) benefited from last week's 12% gain, retail investors stood to gain the mostNovember 18, 2023 | finance.yahoo.comShawn O’Brien Buys Handful Of Shares In Mayne Pharma GroupOctober 28, 2023 | finance.yahoo.comStrong week for Mayne Pharma Group (ASX:MYX) shareholders doesn't alleviate pain of five-year lossOctober 22, 2023 | finance.yahoo.comMayne Pharma Group Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagSeptember 1, 2023 | finance.yahoo.comWilsons Sticks to Its Buy Rating for Mayne Pharma Group (MAYNF)June 13, 2023 | markets.businessinsider.comInfomedia wrangler Viburnum butts heads with Mayne Pharma’s boardMay 16, 2023 | afr.com Get Mayne Pharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MAYNF and its competitors with MarketBeat's FREE daily newsletter. Email Address MAYNF Media Mentions By Week MAYNF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MAYNF News Sentiment▼-0.300.88▲Average Medical News Sentiment MAYNF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MAYNF Articles This Week▼10▲MAYNF Articles Average Week Get Mayne Pharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MAYNF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AstraZeneca News Today Cosmo Pharmaceuticals News Today CSPC Pharmaceutical Group News Today JCR Pharmaceuticals News Today Kyowa Kirin News Today Otsuka News Today Roche News Today Sanofi News Today Scilex News Today Virbac News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MAYNF) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mayne Pharma Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Mayne Pharma Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
